BioMarin Pharmaceutical Inc. Files 8-K for Financial Reporting
Ticker: BMRN · Form: 8-K · Filed: Feb 19, 2025 · CIK: 1048477
| Field | Detail |
|---|---|
| Company | Biomarin Pharmaceutical INC (BMRN) |
| Form Type | 8-K |
| Filed Date | Feb 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: BMRN
TL;DR
BioMarin dropped an 8-K for financial updates, check it for the latest numbers.
AI Summary
BioMarin Pharmaceutical Inc. filed an 8-K on February 19, 2025, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a standard reporting event.
Why It Matters
This filing signals that BioMarin is providing updated financial information and operational disclosures to the SEC, which is important for investors to stay informed about the company's performance.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not appear to contain any new material adverse information.
Key Players & Entities
- BioMarin Pharmaceutical Inc. (company) — Registrant
- February 19, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 68-0397820 (identifier) — I.R.S. Employer Identification No.
- 770 Lindaro Street San Rafael California 94901 (address) — Address of Principal Executive Offices
- 415-506-6700 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are being reported in this 8-K?
The provided text indicates the filing is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific results or updates.
What is the primary purpose of this 8-K filing for BioMarin Pharmaceutical Inc.?
The primary purpose is to report on the company's results of operations and financial condition, and to file necessary financial statements and exhibits with the SEC.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on February 19, 2025.
Where are BioMarin Pharmaceutical Inc.'s principal executive offices located?
BioMarin Pharmaceutical Inc.'s principal executive offices are located at 770 Lindaro Street, San Rafael, California 94901.
What is BioMarin Pharmaceutical Inc.'s IRS Employer Identification Number?
BioMarin Pharmaceutical Inc.'s IRS Employer Identification Number is 68-0397820.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 19, 2025 regarding BIOMARIN PHARMACEUTICAL INC (BMRN).